Optimizing Management of MAC Lung Disease with Guideline-Based Therapy<br><sub>Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD</sub>

Optimizing Management of MAC Lung Disease with Guideline-Based Therapy
Current, Evidence- and Trial-Based Recommendations for Applying ATS/IDSA/ERS/ESCMID Treatment Plans for NTM-PD


Published

August 31, 2022

Created by

CMEducation Resources symposium

Related Presenters

Stefano Aliberti, MD

Stefano Aliberti, MD

Professor in Respiratory Medicine
Humanitas University, Milan, Italy
Chief, Pulmonary Department
IRCCS Humanitas Research Hospital, Milan, Italy
Chair, Italian Registry of Pulmonary Non-Tuberculous Mycobacteria (IRENE)